Market Place
Reply
1. Ibrutinib (140 mg) Hard Capsules. The required quantity is 9,072,000 units.
2. Abiraterone (500 mg) Tablets. The required quantity is 8,100,000 units.
Comments :
pharmahouse@ymail.com
Services offered by PHARMA HOUSE
Dossiers (CTD, e-CTD, ANDA and ANVISA)
(All Country Specific, As per client request)
DMFs(CTD, e-CTD)(Open &Closed part)
(All Regions and Country regulations)
Technology transfers(API'S &Formulations),
( Paper technology & Product Development)
Pharmacovigilance(PV),
Intellectual properties(IP)
We have seperate Teams for Product Development for API'S &Formulations.
All product Documentations (Process, training, trouble shooting)
&other Regulatory services
chowdary@carbontree.in
Dear Sir,
We have exclusive Oncology FDF manufacturing facility with EUGMP, MHRA, Korean GMP, WHOGMP and pic’s approvals and most of the products available eCTD dossiers.
Ibrutinib 140mg hard capsules and Abiraterone Acetate 500mg will be supply with as per your schedules.
Please feel free to visit our website www.spaccurelabs.com
bd@spaccurelabs.com
chowdary@carbontree.in
Dear Sir,
We will supply both Ibrutinib 140 mg capsules and Abiraterone acetate 500mg tablets before 17th September with full quantity once you have provide emergency approval permit. Our manufacturing site has EUGMP, MHRA, Korean GMP, Russian GMP and recently approved Belarus. We look forward to hearing from you soon
Regards
PA Chowdary
Hyderabad, India
Email. bd@spaccurelabs.com
www.spaccurelabs.com
www.tizig.com
hostrinlifesciences@gmail.com
Dear friend,
Greetings from Hostrin Life Sciences!!!
We have been supporting the following services.
1.We do support Tech transfer and Dossiers for Pharmaceutical, Biopharmaceutical, Nutraceutical, Biotech and Biosimilars in CTD, eCTD, ACTD, ANDA. DMF's for API's, Tech transfer support and Registration of Dossiers in MOH /MHRA/EMEA/FDA with 5 modules including BA and BE studies /Clinical studies/trials for finished formulation's in Pharmaceutical, ayurveda, Biotech, Biosimilar, vitamins , Peptides and Transdermal patches too.
2. eCTD publishing with potential software, addressing post submission queries from all regulatory authorities and all type of mock audits like USFDA_21_CFR with GAP filling for USFDA, WHO-GMP, EU-GMP, MHRA, TGA, PMDA and PICS audits as well.
3. Impurity's & Reference standards support for API's
4. Services for IPR & Regulatory compliance
5. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.
6. Custom synthesis and contract manufacturing services
7. Synthetic Resins technologies support.
8. Cleaning validation/ toxicology studies reports (PD values) for commercial manufacturing of APIs and finished formulations.
9. Pharmacovigilance services.
Pls don't hesitate to send your inquiries. For your reference, please go through our website www.hostringlobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343
